ECEPAS- Ethics Community Engagement And Patient Advocacy And Support
The Global Emerging Pathogens Treatment Consortium (GET) is made up of African experts who assembled in the wake of the ebola epidemic. The consortium collaborated with partners from the United States, Europe and Asia. The first objective was to assess the efficacy of Ebola Immune Plasma or Globulin in acute Ebola Virus Disease (EVD) in the 2014 Ebola Zaire (EBOZ) West African outbreak. There is no known cure for Ebola, however there is convincing evidence, that the disease can be prevented, and its severity curtailed by the use of plasma from survivors. The African-led effort was comprised of experts in the fields of Infectious diseases, various subspecialties of pathology, haematology, blood transfusion, physicians, bioinformatics, biobanking, ethics, social science, community engagement, patient advocates, logistics, engineers and government administrators. The consortium worked rapidly to organize and establish a plasmapheresis and plasma processing and storage facility in West Africa and to conduct clinical trials to assess efficacy.